ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade

Zhao, Zhiyu; Dong, Shuming; Liu, Yue; Wang, Jianxin; Ba, Li; Zhang, Cong; Cao, Xinyu; Wu, Changjun*; Yang, Piaoping*哈尔滨工程大学test; 哈尔滨医科大学; 1
ACS Nano2022-11-28DOI: 10.1021/acsnano.2c06646
24被引10阅读
引用收藏
分享

摘要

Immune checkpoint blockade (ICB) therapy has attracted widespread attention in cancer treatment. Due to the low immunogenicity and immune suppression state in the tumor microenvironment (TME), the therapeutic effects are only moderate. Herein, a TME-activable manganese-boosted catalytic immunotherapy is designed for synergism with ICB therapy to kill tumors efficiently. The tumor cell membrane (CM)-wrapping multienzyme-mimic manganese oxide (MnOx) nanozyme termed CM@Mn showed intrinsic peroxidase and oxidase-like activities in an acidic TME. These activities can generate toxic hydroxyl (center dot OH) and superoxide radicals (center dot O2-) for tumor cell killing and evoking immunogenic cell death (ICD). Furthermore, the TME-responsive release of Mn2+ directly promotes dendritic cell maturation and macrophage M1 repolarization, resulting in the reversal of an immunosuppressive TME into an immune-activating environment. Additionally, tumor hypoxia relief caused by catalase-like activity also contributes to the process of TME reversal. Finally, a robust tumor-specific T cell-mediated antitumor response occurs with the support of the PD-1 checkpoint blockade. The proliferation of primary and metastatic tumors was inhibited, and a long-term immune memory effect was induced. The therapeutic strategy outlined here may serve as a promising candidate for tumor-integrated treatment.

学科与关键词

关键词
catalytic immunotherapyimmune activationimmune checkpoint blockadeimmunogenic cell deathmanganese
相关
加载中…
  • A Sub-6 nm MnFe2O4-dichloroacetic acid nanocomposite modulates tumor metabolism and catabolism for reversing tumor immunosuppressive microenvironment and boosting immunotherapy
    Dai, Zan; Wang, Qiaoyun; Tang, Jie*; Qu, Rui; Wu, Min; Li, Haoze; Yang, Yannan; Zhen, Xu*; Yu, Chengzhong*Biomaterials, 2022, 284: 121533.被引 17
  • Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy
    Huang, Cong; Lin, Bingquan; Chen, Chuyao; Wang, Huaiming; Lin, Xiaosheng; Liu, Jiamin; Ren, Qingfan; Tao, Jia*; Zhao, Peng*; Xu, Yikai*Advanced Materials, 2022, 34(51).被引 47
  • A Mild Hyperthermia Hollow Carbon Nanozyme as Pyroptosis Inducer for Boosted Antitumor Immunity
    Tao, Na; Jiao, Lei; Li, Huihuang; Deng, Liu*; Wang, Wei; Zhao, Senfeng; Chen, Wansong; Chen, Limiao; Zhu, Chengzhou*; Liu, You-Nian*ACS Nano, 2023, 17(22): 22844-22858.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
ACS Nano
发表日期
2022-11-28
卷期
第 16 卷, 第 12 期
页码
20400-20418
DOI
10.1021/acsnano.2c06646
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Natural Science Foundation of Shandong Province; Fundamental Research Funds for the Central Universities; [NSFC 52002091]; [51972075]; [U22A20347]; [ZR2020ZD42]

作者

  • Z

    Zhao, Zhiyu (第一作者)

    1 · harbin med univ

  • D

    Dong, Shuming

    harbin engn univ

查看全部 9 位作者收起作者
  • L

    Liu, Yue

    1 · harbin med univ

  • W

    Wang, Jianxin

    1 · harbin med univ

  • B

    Ba, Li

    1 · harbin med univ

  • Z

    Zhang, Cong

    1 · harbin med univ

  • C

    Cao, Xinyu

    1 · harbin med univ

  • W

    Wu, Changjun (通讯)

    1 · harbin med univ

  • Y

    Yang, Piaoping (通讯)

    harbin engn univ · 1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417